Ceramide kinase is required for a normal eicosanoid response and the subsequent orderly migration of fi broblasts

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1298-1309

  Wijesinghe, Dayanjan S ^a,b   Brentnall, Matthew ^c,d   Mietla, Jennifer A ^a   Hoeferlin, L Alexis ^a   Diegelmann, Robert F ^a   Boise, Lawrence H ^c   Chalfant, Charles E ^a,b,e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

Ceramide 1 phosphate; Lipidomics; Wound healing

Indexed keywords

ARACHIDONIC ACID; CERAMIDE 1 PHOSPHATE; CERAMIDE KINASE; ICOSANOID; CERAMIDE; CERAMIDE 1-PHOSPHATE; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL MIGRATION; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; FEMALE; GENE LOSS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INJURY; WOUND HEALING; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CELL MOVEMENT; CERAMIDES; EICOSANOIDS; FIBROBLASTS; MICE; MICE, KNOCKOUT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); WOUND HEALING;

EID: 84904015438     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M048207     Document Type: Article

References (30)

1. Goldberg, S. R., and R. F. Diegelmann. 2010. Wound healing primer. Surg. Clin. North Am. 90: 1133-1146.
2. Berry, D. P., K. G. Harding, M. R. Stanton, B. Jasani, and H. P. Ehrlich. 1998. Human wound contraction: collagen organization, fi broblasts, and myofi broblasts. Plast. Reconstr. Surg. 102: 124-131, discussion 132-134.
3. Xu, F., C. Zhang, and D. T. Graves. 2013. Abnormal cell responses and role of TNF-in impaired diabetic wound healing. Biomed. Res. Int. 2013: 754802.
4. Suganuma, H., A. Sato, R. Tamura, and K. Chida. 1995. Enhanced migration of fi broblasts derived from lungs with fi brotic lesions. Thorax. 50: 984-989.
5. White, E. S., R. G. Atrasz, E. G. Dickie, D. M. Aronoff, V. Stambolic, T. W. Mak, B. B. Moore, and M. Peters-Golden. 2005. Prostaglandin E2 inhibits fi broblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am. J. Respir. Cell Mol. Biol. 32: 135-141.
6. Huang, S. K., and M. Peters-Golden. 2008. Eicosanoid lipid mediators in fi brotic lung diseases: ready for prime time? Chest. 133: 1442-1450.
7. Rieger, G. M., R. Hein, B. C. Adelmann-Grill, T. Ruzicka, and T. Krieg. 1990. Infl uence of eicosanoids on fi broblast chemotaxis and protein synthesis in vitro. J. Dermatol. Sci. 1: 347-354.
8. Green, J. A., R. A. Stockton, C. Johnson, and B. S. Jacobson. 2004. 5-Lipoxygenase and cyclooxygenase regulate wound closure in NIH/3T3 fi broblast monolayers. Am. J. Physiol. Cell Physiol. 287: C373-C383.
9. Kohyama, T., X. Liu, H. J. Kim, T. Kobayashi, R. F. Ertl, F-Q. Wen, H. Takizawa, and S. I. Rennard. 2002. Prostacyclin analogs inhibit fi broblast migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L428-L432.
10. Nieves, D., and J. J. Moreno. 2006. Hydroxyeicosatetraenoic acids released through the cytochrome P-450 pathway regulate 3T6 fi-broblast growth. J. Lipid Res. 47: 2681-2689.
11. Su, W-H., M-H. Cheng, W-L. Lee, T-S. Tsou, W-H. Chang, C-S. Chen, and P-H. Wang. 2010. Nonsteroidal anti-infl ammatory drugs for wounds: pain relief or excessive scar formation? Mediators Infl amm. 2010: 413238.
12. Pettus, B. J., A. Bielawska, P. Subramanian, D. S. Wijesinghe, M. Maceyka, C. C. Leslie, J. H. Evans, J. Freiberg, P. Roddy, Y. A. Hannun, et al. 2004. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279: 11320-11326.
13. Pettus, B. J., A. Bielawska, S. Spiegel, P. Roddy, Y. A. Hannun, and C. E. Chalfant. 2003. Ceramide kinase mediates cytokine-and calcium ionophore-induced arachidonic acid release. J. Biol. Chem. 278: 38206-38213.
14. Subramanian, P., R. V. Stahelin, Z. Szulc, A. Bielawska, W. Cho, and C. E. Chalfant. 2005. Ceramide 1-phosphate acts as a positive allostericactivator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. J. Biol. Chem. 280: 17601-17607.
15. Subramanian, P., M. Vora, L. B. Gentile, R. V. Stahelin, and C. E. Chalfant. 2007. Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms. J. Lipid Res. 48: 2701-2708.
16. Lamour, N. F., P. Subramanian, D. S. Wijesinghe, R. V. Stahelin, J. V. Bonventre, and C. E. Chalfant. 2009. Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis. J. Biol. Chem. 284: 26897-26907.
17. Wijesinghe, D. S., P. Subramanian, N. F. Lamour, L. B. Gentile, M. H. Granado, A. Bielawska, Z. Szulc, A. Gomez-Munoz, and C. E. Chalfant. 2009. Chain length specifi city for activation of cPLA2-by C1P: use of the dodecane delivery system to determine lipidspecifi c effects. J. Lipid Res. 50: 1986-1995.
18. Wijesinghe, D. S., J. C. Allegood, L. B. Gentile, T. E. Fox, M. Kester, and C. E. Chalfant. 2010. Use of high performance liquid chromatographyelectrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels. J. Lipid Res. 51: 641-651.
19. Simanshu, D. K., R. K. Kamlekar, D. S. Wijesinghe, X. Zou, X. Zhai, S. K. Mishra, J. G. Molotkovsky, L. Malinina, E. H. Hinchcliffe, C. E. Chalfant, et al. 2013. Non-vesicular traffi cking by a ceramide-1-phosphate transfer protein regulates eicosanoids. Nature. 500: 463-467.
20. Mietla, J. A., D. S. Wijesinghe, L. A. Hoeferlin, M. D. Shultz, R. Natarajan, A. A. Fowler, and C. E. Chalfant. 2013. Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase. J. Lipid Res. 54: 1834-1847.
21. Graf, C., B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Muller, E. Fischer, C. Reichel, et al. 2008. Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-defi cient mice. J. Immunol. 180: 3457-3466.
22. Velnar, T., T. Bailey, and V. Smrkolj. 2009. The wound healing process: an overview of the cellular and molecular mechanisms. J. Int. Med. Res. 37: 1528-1542.
23. Graf, C., S. Niwa, M. M̈ller, B. Kinzel, and F. Bornancin. 2008. Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-defi cient mice. Biochem. Biophys. Res. Commun. 373: 159-163.
24. Werner, S., T. Krieg, and H. Smola. 2007. Keratinocyte-fi broblast interactions in wound healing. J. Invest. Dermatol. 127: 998-1008.
25. Pentland, A. P., and P. Needleman. 1986. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest. 77: 246-251.
26. Blacker, K. L., M. L. Williams, and M. Goldyne. 1987. Mitomycin C-treated 3T3 fi broblasts used as feeder layers for human keratinocyte culture retain the capacity to generate eicosanoids. J. Invest. Dermatol. 89: 536-539.
27. Kim, C., G. Schneider, A. Abdel-Latif, K. Mierzejewska, M. Sunkara, S. Borkowska, J. Ratajczak, A. J. Morris, M. Kucia, and M. Z. Ratajczak. 2013. Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cellsimplications for tissue regeneration. Stem Cells. 31: 500-510.
28. Wynn, T. A. 2007. Common and unique mechanisms regulate fi-brosis in various fi broproliferative diseases. J. Clin. Invest. 117: 524-529.
29. Liliental, J., S. Y. Moon, R. Lesche, R. Mamillapalli, D. Li, Y. Zheng, H. Sun, and H. Wu. 2000. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10: 401-404.
30. Wong, P. Y., W. H. Lee, P. H. Chao, R. F. Reiss, and J. C. McGiff. 1980. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purifi cation. J. Biol. Chem. 255: 9021-9024.